Biomarkers Before the Crisis

Analyze the value of biomarkers and other early-detection methods for dangerous poisoning or exposure events. Compare the scientific, clinical, legal, and public-health tradeoffs of detecting harm sooner: Who benefits most, what false positives or delays matter, how should testing be validated, and how do such tools change emergency response, forensic investigations, and workplace safety policies?